Tübingen, Germany

Curevac Gmbh

Calculating rank
USPTO Granted Patents = 5

% Expired Patents = 40.0


Trademarks = 7

Forward Citations = 507

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Florian Von Der Mülbe (3 out of 20 patents)

silverMedal Steve Pascolo (2 out of 24 patents)

bronzeMedal Patrick Baumhof (2 out of 22 patents)

4.  Ingmar Hoerr (2 out of 22 patents)

5.  Thomas Kramps (1 out of 26 patents)

6.  Thomas Schlake (1 out of 33 patents)

7.  Thomas Ketterer (1 out of 25 patents)

8.  Thorsten Mutzke (1 out of 22 patents)

9.  Karl-Josef Kallen (1 out of 29 patents)

10.  Ladislaus Reidel (1 out of 5 patents)

11.  Söhnke Voss (1 out of 4 patents)

12.  Andreas Thess (67 patents)

13.  Jochen Probst (37 patents)

14.  Mariola Fotin-Mleczek (28 patents)

15.  Günther Jung (1 patent)


5 patents:

Company Overview
Curevac is a leading clinical-stage biopharmaceutical company focused on developing a new class of transformative medicines based on messenger RNA (mRNA). The company's innovative technology platform allows for the production of potent mRNA therapeutics for the treatment of a wide range of diseases, including infectious diseases and cancer.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#25 in Tübingen

#6,102 in Germany

Tübingen, DE
Tübingen, Germany
Forward Citations = 507

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Curevac Gmbh. Retrieved from https://idiyas.com/company/curevac

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…